Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-17

Glycosaminoglycans and their oligosaccharides derivatives : new opportunities in drug discovery.

Objective

The Glycosaminoglycans are biological polymers, which plays key roles in numerous biological processes. Glycosaminoglycan is mainly represented by heparin, heparan sulfate, chondoitins ABC and hyaluronic acid. Their structural heterogeneity and complexity is mainly linked to their sulfation degree. From basic disaccharide repeating units to highly complex disaccharide arrangement in the heparin backbone, a world of infinite structural diversity and oligosaccharide sequence is encompassed. The most fascinating is undoubtedly heparin. Through a specific interaction with antithrombine III, this polysaccharide is able to inhibit proteases involved in coagulation cascade. However, heparin is also able to interact with many proteins and its now obvious that particular sequences mediates other biological process than haemostasis (i.e. angiogenesis). For example, heparin discrete domains promote or inhibit cells proliferation through FGFs interaction. Again, other parts of the macromolecule are able to inhibit so-called inflammatory processes. Our goal is to disconnect the different biological properties of heparin by synthesizing specific oligosaccharidic sequences. This concept is extended to the other GAGs like chondroitins. The postdoctoral fellows will have to address GAGs specific issues in hemi-synthesis / total synthesis in other to prepare the targeted oligosaccharides.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Data not available

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

Data not available

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

BUR - Bursaries, grants, fellowships

Coordinator

AVENTIS PHARMA RECHERCHE DEVELOPPEMENT S.A.
EU contribution
No data
Address
Quai Jules Guesde 13
94400 VITRY SUR SEINE
France

See on map

Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data
My booklet 0 0